Impaired Glomerular Filtration Rate in Type 2 Diabetes Mellitus Subjects: A Nationwide Cross-Sectional Study in Thailand
Overview
Affiliations
Background: Type 2 diabetic mellitus (T2DM) patients with impaired renal function have a higher risk of mortality, and often progress to end-stage renal disease. The study aims to determine the prevalence of kidney disease and investigate the relationship between various factors and impaired renal function in a large population of patients with T2DM.
Methods: We conducted a cross-sectional study among 30,377 patients from a nationwide diabetes study involving 602 Thai hospitals. Impaired glomerular filtration rate (GFR) was defined as <60 mL/min per 1.73 m. Multivariate logistic regression was used to determine the association between standard risk factors and impaired GFR.
Results: The prevalence of impaired GFR in a T2DM population was 39.2%. After adjusting for multiple risk factors, advanced age (adjusted OR 11.69 (95%CI = 3.13 to 43.61)), macroalbuminuria (adjusted OR 3.54 (95%CI = 1.50 to 8.40)), high serum uric acid (adjusted OR 2.06 (95%CI = 1.73 to 2.46)), systolic BP 130-139 mmHg (adjusted OR 3.21 (95%CI = 1.30 to 7.96)), hemoglobinA1C (HA1C) <6% (adjusted OR 3.71 (95%CI = 1.65 to 8.32)), and HA1C >7% (adjusted OR 2.53 (95%CI = 1.38 to 4.63)) were found to be associated with a significantly increased risk of impaired GFR among T2DM patients.
Conclusion: Almost 40% of patients with T2DM in a nationwide cross-sectional study in Thailand had impaired GFR. Advanced age, albuminuria, hyperuricemia, hypertension, HA1C <6%, and HA1C >7% were independently associated with increased prevalence of impaired GFR.
polymorphism rs1065852 significantly increases the risk of type 2 diabetes.
Wei H, Zhao Q Ann Med. 2025; 57(1):2470956.
PMID: 40028882 PMC: 11878161. DOI: 10.1080/07853890.2025.2470956.
Hypertension in Adults With Diabetes in Southeast Asia: A Systematic Review.
Wong W, Van Nguyen T, Ahmad F, Vu H, Koh A, Tan K J Clin Hypertens (Greenwich). 2024; 27(1):e14936.
PMID: 39545715 PMC: 11771803. DOI: 10.1111/jch.14936.
Gela Y, Belay D, Belsti Y, Getahun A, Getnet M, Bitew D Sci Rep. 2024; 14(1):25143.
PMID: 39448700 PMC: 11502774. DOI: 10.1038/s41598-024-77318-5.
Implications of pregnancy on cardiometabolic disease risk: preeclampsia and gestational diabetes.
Elgazzaz M, Woodham P, Maher J, Faulkner J Am J Physiol Cell Physiol. 2024; 327(3):C646-C660.
PMID: 39010840 PMC: 11427017. DOI: 10.1152/ajpcell.00293.2024.
Khanal M, Bhandari P, Dhungana R, Gurung Y, Rawal L, Pandey G J Diabetes Investig. 2023; 14(4):602-613.
PMID: 36747483 PMC: 10034961. DOI: 10.1111/jdi.13985.